CAIHF (CPBIO Holding Co) Total Liabilities: $153.8 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAIHF CPBIO Holding Co Ltd CAIHF
71 GF Score
Price $0.28
GF Value $0.14
! 4 Warning Signs
View Full Analysis

What is CPBIO Holding Co Total Liabilities?

CPBIO Holding Co CAIHF 71 Total Liabilities is $153.8 Mil as of Dec. 2025. GuruFocus rates CAIHF with a GF Score™ of 71/100 and a GF Value™ of $0.14. The stock has 4 warning signs investors should review.

CPBIO Holding Co's Total Liabilities for the quarter that ended in Dec. 2025 was $153.8 Mil.

CPBIO Holding Co's quarterly Total Liabilities declined from Jun. 2025 ($163.63 Mil) to Sep. 2025 ($152.89 Mil) but then increased from Sep. 2025 ($152.89 Mil) to Dec. 2025 ($153.78 Mil).

CPBIO Holding Co's annual Total Liabilities increased from Dec. 2023 ($125.36 Mil) to Dec. 2024 ($161.70 Mil) but then declined from Dec. 2024 ($161.70 Mil) to Dec. 2025 ($153.78 Mil).

CPBIO Holding Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for CPBIO Holding Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CPBIO Holding Co Total Liabilities Chart

CPBIO Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 81.69 94.83 125.36 161.70 153.78

CPBIO Holding Co Quarterly Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 172.99 163.63 152.89 153.78 162.07
CAIHF
71GF Score
CPBIO Holding Co Ltd CAIHF
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CPBIO Holding Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

CPBIO Holding Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=137.538+(9.04+7.205
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=153.8

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=461.664-307.881
=153.8

CPBIO Holding Co's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=137.538+(9.04+7.205
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=153.8

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=461.664-307.881
=153.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $153.8 Mil mean?
CPBIO Holding Co (CAIHF) has a Total Liabilities of $153.8 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for CPBIO Holding Co and its competitors.
Is CPBIO Holding Co's Total Liabilities too high?
CPBIO Holding Co's current Total Liabilities is $153.8 Mil. Overall, CPBIO Holding Co has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does CPBIO Holding Co's Total Liabilities compare to ZTS?
CPBIO Holding Co's Total Liabilities of $153.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for CPBIO Holding Co and its competitors. CPBIO Holding Co's current Total Liabilities is $153.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CPBIO Holding Co stock overvalued right now?
CPBIO Holding Co (CAIHF) has a current Total Liabilities of $153.8 Mil. The stock's GF Value™ is $0.14, compared to a current price of $0.28 — trading 100% above its estimated fair value. The current Total Liabilities is $153.8 Mil. CPBIO Holding Co's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For CPBIO Holding Co (CAIHF), the current Total Liabilities is $153.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CPBIO Holding Co (CAIHF) Overvalued in 2026?

Based on GuruFocus' analysis, CPBIO Holding Co stock appears to be overvalued. The current stock price of $0.28 is trading 100% above its estimated GF Value™ of $0.14.

Key valuation signals for CAIHF:

  • Total Liabilities: $153.8 Mil
  • GF Value™: $0.14 vs. price of $0.28 (100% above fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the CAIHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CPBIO Holding Co Business Description

Other Exchanges 03839:Hong Kong
Address 16 Harcourt Road, 21st Floor, Far East Finance Centre, Central, Hong Kong, HKG
Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of animal health products and chlortetracycline (CTC). The group has two reportable segments: Biotech Business and Investment Business. The Biotech Business segment is involved in the manufacture and/or sale of animal health products and chlortetracycline. The Investment Business segment is engaged in the trading of machinery and the manufacture and sale of automotive parts through the group's joint ventures and associates. It generates the majority of its revenue from the Biotech Business segment. Its geographical segments are Mainland China, which generates key revenue, Asia Pacific (excluding mainland China), the Americas, Europe, and Others.
71GF Score

Get the complete analysis for CAIHF

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28
Price
$0.14
GF Value